Table 1 Patient characteristics
No | GroupA | GroupB | P-value | |
|---|---|---|---|---|
Total | 410 | 170 | 240 | |
Age (years) | 0.257 | |||
Median | 54 | 51 | ||
Range | 29–72 | 28–71 | ||
Serum CA-125 level (U/mL) | 0.532 | |||
Median | 606.8 | 455.1 | ||
Range | 13–6743 | 6–10,000 | ||
Intraoperative blood loss (ml) | 0.889 | |||
Mean | 537.7 ± 335.3 | 542.5 ± 352.4 | ||
Range | 100–1500 | 100–2200 | ||
Histology | 0.475 | |||
Serous | 320 | 136 (80%) | 184 (76.7%) | |
Clear cell | 6 | 4 (2.4%) | 2 (0.8%) | |
Endometrioid | 46 | 16 (9.4%) | 30 (12.5%) | |
Mucinous | 24 | 10 (5.9%) | 14 (5.8%) | |
Others | 14 | 4 (2.4%) | 10 (4.2%) | |
FIGO stage | 0.686 | |||
III | 342 | 140 (82.4%) | 202 (84.2%) | |
IV | 68 | 30 (17.6%) | 38 (15.8%) |